The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
  • lennivelkant@discuss.tchncs.de
    0·
    5 个月前

    so it’s hard to know exactly what to make of the results

    Sounds like someone desperately trying to not ruin future grant chances by saying “this trial is absolutely worthless”…